Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
1,052
archived clinical trials in
Nephrology

Evaluation of Patients With Known or Suspected Heart Disease
Evaluation of Patients With Known or Suspected Heart Disease (Screening Protocol)
Status: Enrolling
Updated:  9/26/2015
Suburban Hospital
mi
from
Bethesda, MD
Evaluation of Patients With Known or Suspected Heart Disease
Evaluation of Patients With Known or Suspected Heart Disease (Screening Protocol)
Status: Enrolling
Updated: 9/26/2015
Suburban Hospital
mi
from
Bethesda, MD
Click here to add this to my saved trials
Evaluation of Patients With Known or Suspected Heart Disease
Evaluation of Patients With Known or Suspected Heart Disease (Screening Protocol)
Status: Enrolling
Updated:  9/26/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Evaluation of Patients With Known or Suspected Heart Disease
Evaluation of Patients With Known or Suspected Heart Disease (Screening Protocol)
Status: Enrolling
Updated: 9/26/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Salivary Proteins in Disease and Health
Salivary Proteomics in Disease and Health
Status: Enrolling
Updated:  9/26/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Salivary Proteins in Disease and Health
Salivary Proteomics in Disease and Health
Status: Enrolling
Updated: 9/26/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Lupus Nephritis: Role of Environmental and Occupational Exposures
Lupus Nephritis: Role of Environmental and Occupational Exposures
Status: Enrolling
Updated:  9/26/2015
Univ of North Carolina
mi
from
Chapel Hill, NC
Lupus Nephritis: Role of Environmental and Occupational Exposures
Lupus Nephritis: Role of Environmental and Occupational Exposures
Status: Enrolling
Updated: 9/26/2015
Univ of North Carolina
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Lupus Nephritis: Role of Environmental and Occupational Exposures
Lupus Nephritis: Role of Environmental and Occupational Exposures
Status: Enrolling
Updated:  9/26/2015
NIEHS, Research Triangle Park
mi
from
Research Triangle Park, NC
Lupus Nephritis: Role of Environmental and Occupational Exposures
Lupus Nephritis: Role of Environmental and Occupational Exposures
Status: Enrolling
Updated: 9/26/2015
NIEHS, Research Triangle Park
mi
from
Research Triangle Park, NC
Click here to add this to my saved trials
Potassium Citrate Supplementation vs. Dietary Counseling
Does Potassium Citrate Supplementation Reduce Stone Recurrence in Calcium Phosphate Stone Formers With Risk Factors?
Status: Enrolling
Updated:  10/7/2015
North Carolina Memorial Hospital
mi
from
Chapel Hill, NC
Potassium Citrate Supplementation vs. Dietary Counseling
Does Potassium Citrate Supplementation Reduce Stone Recurrence in Calcium Phosphate Stone Formers With Risk Factors?
Status: Enrolling
Updated: 10/7/2015
North Carolina Memorial Hospital
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
MSC for Occlusive Disease of the Kidney
Phase I Study of Autologous Mesenchymal Stem Cells in the Treatment of Atherosclerotic Renal Artery Stenosis
Status: Enrolling
Updated:  10/8/2015
Mayo Clinic Rochester
mi
from
Rochester, MN
MSC for Occlusive Disease of the Kidney
Phase I Study of Autologous Mesenchymal Stem Cells in the Treatment of Atherosclerotic Renal Artery Stenosis
Status: Enrolling
Updated: 10/8/2015
Mayo Clinic Rochester
mi
from
Rochester, MN
Click here to add this to my saved trials
Rituximab in the Treatment of Idiopathic Membranous Nephropathy
Rituximab in the Treatment of Idiopathic Membranous Nephropathy
Status: Enrolling
Updated:  10/23/2015
The Mayo Clinic
mi
from
Rochester, MN
Rituximab in the Treatment of Idiopathic Membranous Nephropathy
Rituximab in the Treatment of Idiopathic Membranous Nephropathy
Status: Enrolling
Updated: 10/23/2015
The Mayo Clinic
mi
from
Rochester, MN
Click here to add this to my saved trials
BIIB023 Proof-of-Concept Study in Participants With Lupus Nephritis
A Multicenter, Randomized, Double Blind, Placebo Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of BIIB023 in Subjects With Lupus Nephritis
Status: Enrolling
Updated:  11/12/2015
Clinical Research Facility
mi
from
Torrance, CA
BIIB023 Proof-of-Concept Study in Participants With Lupus Nephritis
A Multicenter, Randomized, Double Blind, Placebo Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of BIIB023 in Subjects With Lupus Nephritis
Status: Enrolling
Updated: 11/12/2015
Clinical Research Facility
mi
from
Torrance, CA
Click here to add this to my saved trials
BIIB023 Proof-of-Concept Study in Participants With Lupus Nephritis
A Multicenter, Randomized, Double Blind, Placebo Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of BIIB023 in Subjects With Lupus Nephritis
Status: Enrolling
Updated:  11/12/2015
Clinical Research Facility
mi
from
Orlando, FL
BIIB023 Proof-of-Concept Study in Participants With Lupus Nephritis
A Multicenter, Randomized, Double Blind, Placebo Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of BIIB023 in Subjects With Lupus Nephritis
Status: Enrolling
Updated: 11/12/2015
Clinical Research Facility
mi
from
Orlando, FL
Click here to add this to my saved trials
BIIB023 Proof-of-Concept Study in Participants With Lupus Nephritis
A Multicenter, Randomized, Double Blind, Placebo Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of BIIB023 in Subjects With Lupus Nephritis
Status: Enrolling
Updated:  11/12/2015
Clinical Research Facility
mi
from
Boston, MA
BIIB023 Proof-of-Concept Study in Participants With Lupus Nephritis
A Multicenter, Randomized, Double Blind, Placebo Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of BIIB023 in Subjects With Lupus Nephritis
Status: Enrolling
Updated: 11/12/2015
Clinical Research Facility
mi
from
Boston, MA
Click here to add this to my saved trials
BIIB023 Proof-of-Concept Study in Participants With Lupus Nephritis
A Multicenter, Randomized, Double Blind, Placebo Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of BIIB023 in Subjects With Lupus Nephritis
Status: Enrolling
Updated:  11/12/2015
Clinical Research Facility
mi
from
Great Neck, NY
BIIB023 Proof-of-Concept Study in Participants With Lupus Nephritis
A Multicenter, Randomized, Double Blind, Placebo Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of BIIB023 in Subjects With Lupus Nephritis
Status: Enrolling
Updated: 11/12/2015
Clinical Research Facility
mi
from
Great Neck, NY
Click here to add this to my saved trials
BIIB023 Proof-of-Concept Study in Participants With Lupus Nephritis
A Multicenter, Randomized, Double Blind, Placebo Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of BIIB023 in Subjects With Lupus Nephritis
Status: Enrolling
Updated:  11/12/2015
Clinical Research Facility
mi
from
Chapel Hill, NC
BIIB023 Proof-of-Concept Study in Participants With Lupus Nephritis
A Multicenter, Randomized, Double Blind, Placebo Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of BIIB023 in Subjects With Lupus Nephritis
Status: Enrolling
Updated: 11/12/2015
Clinical Research Facility
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
BIIB023 Proof-of-Concept Study in Participants With Lupus Nephritis
A Multicenter, Randomized, Double Blind, Placebo Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of BIIB023 in Subjects With Lupus Nephritis
Status: Enrolling
Updated:  11/12/2015
Clinical Research Facility
mi
from
Columbus, OH
BIIB023 Proof-of-Concept Study in Participants With Lupus Nephritis
A Multicenter, Randomized, Double Blind, Placebo Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of BIIB023 in Subjects With Lupus Nephritis
Status: Enrolling
Updated: 11/12/2015
Clinical Research Facility
mi
from
Columbus, OH
Click here to add this to my saved trials
BIIB023 Proof-of-Concept Study in Participants With Lupus Nephritis
A Multicenter, Randomized, Double Blind, Placebo Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of BIIB023 in Subjects With Lupus Nephritis
Status: Enrolling
Updated:  11/12/2015
Clinical Research Facility
mi
from
Memphis, TN
BIIB023 Proof-of-Concept Study in Participants With Lupus Nephritis
A Multicenter, Randomized, Double Blind, Placebo Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of BIIB023 in Subjects With Lupus Nephritis
Status: Enrolling
Updated: 11/12/2015
Clinical Research Facility
mi
from
Memphis, TN
Click here to add this to my saved trials
BIIB023 Proof-of-Concept Study in Participants With Lupus Nephritis
A Multicenter, Randomized, Double Blind, Placebo Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of BIIB023 in Subjects With Lupus Nephritis
Status: Enrolling
Updated:  11/12/2015
Clinical Research Facility
mi
from
El Paso, TX
BIIB023 Proof-of-Concept Study in Participants With Lupus Nephritis
A Multicenter, Randomized, Double Blind, Placebo Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of BIIB023 in Subjects With Lupus Nephritis
Status: Enrolling
Updated: 11/12/2015
Clinical Research Facility
mi
from
El Paso, TX
Click here to add this to my saved trials
BIIB023 Long-Term Extension Study in Subjects With Lupus Nephritis
A Dose-Blinded, 2-Dose Level, Parallel-Group, Multicenter, Long-Term Extension Study to Evaluate the Long-Term Safety, Efficacy, and Immunogenicity of BIIB023 in Subjects With Lupus Nephritis
Status: Enrolling
Updated:  11/12/2015
Clinical Research Facility
mi
from
Boston, MA
BIIB023 Long-Term Extension Study in Subjects With Lupus Nephritis
A Dose-Blinded, 2-Dose Level, Parallel-Group, Multicenter, Long-Term Extension Study to Evaluate the Long-Term Safety, Efficacy, and Immunogenicity of BIIB023 in Subjects With Lupus Nephritis
Status: Enrolling
Updated: 11/12/2015
Clinical Research Facility
mi
from
Boston, MA
Click here to add this to my saved trials
BIIB023 Long-Term Extension Study in Subjects With Lupus Nephritis
A Dose-Blinded, 2-Dose Level, Parallel-Group, Multicenter, Long-Term Extension Study to Evaluate the Long-Term Safety, Efficacy, and Immunogenicity of BIIB023 in Subjects With Lupus Nephritis
Status: Enrolling
Updated:  11/12/2015
Clinical Research Facility
mi
from
Great Neck, NY
BIIB023 Long-Term Extension Study in Subjects With Lupus Nephritis
A Dose-Blinded, 2-Dose Level, Parallel-Group, Multicenter, Long-Term Extension Study to Evaluate the Long-Term Safety, Efficacy, and Immunogenicity of BIIB023 in Subjects With Lupus Nephritis
Status: Enrolling
Updated: 11/12/2015
Clinical Research Facility
mi
from
Great Neck, NY
Click here to add this to my saved trials
BIIB023 Long-Term Extension Study in Subjects With Lupus Nephritis
A Dose-Blinded, 2-Dose Level, Parallel-Group, Multicenter, Long-Term Extension Study to Evaluate the Long-Term Safety, Efficacy, and Immunogenicity of BIIB023 in Subjects With Lupus Nephritis
Status: Enrolling
Updated:  11/12/2015
Clinical Research Facility
mi
from
Columbus, OH
BIIB023 Long-Term Extension Study in Subjects With Lupus Nephritis
A Dose-Blinded, 2-Dose Level, Parallel-Group, Multicenter, Long-Term Extension Study to Evaluate the Long-Term Safety, Efficacy, and Immunogenicity of BIIB023 in Subjects With Lupus Nephritis
Status: Enrolling
Updated: 11/12/2015
Clinical Research Facility
mi
from
Columbus, OH
Click here to add this to my saved trials
BIIB023 Long-Term Extension Study in Subjects With Lupus Nephritis
A Dose-Blinded, 2-Dose Level, Parallel-Group, Multicenter, Long-Term Extension Study to Evaluate the Long-Term Safety, Efficacy, and Immunogenicity of BIIB023 in Subjects With Lupus Nephritis
Status: Enrolling
Updated:  11/12/2015
Clinical Research Facility
mi
from
Memphis, TN
BIIB023 Long-Term Extension Study in Subjects With Lupus Nephritis
A Dose-Blinded, 2-Dose Level, Parallel-Group, Multicenter, Long-Term Extension Study to Evaluate the Long-Term Safety, Efficacy, and Immunogenicity of BIIB023 in Subjects With Lupus Nephritis
Status: Enrolling
Updated: 11/12/2015
Clinical Research Facility
mi
from
Memphis, TN
Click here to add this to my saved trials
BIIB023 Long-Term Extension Study in Subjects With Lupus Nephritis
A Dose-Blinded, 2-Dose Level, Parallel-Group, Multicenter, Long-Term Extension Study to Evaluate the Long-Term Safety, Efficacy, and Immunogenicity of BIIB023 in Subjects With Lupus Nephritis
Status: Enrolling
Updated:  11/12/2015
Clinical Research Facility
mi
from
El Paso, TX
BIIB023 Long-Term Extension Study in Subjects With Lupus Nephritis
A Dose-Blinded, 2-Dose Level, Parallel-Group, Multicenter, Long-Term Extension Study to Evaluate the Long-Term Safety, Efficacy, and Immunogenicity of BIIB023 in Subjects With Lupus Nephritis
Status: Enrolling
Updated: 11/12/2015
Clinical Research Facility
mi
from
El Paso, TX
Click here to add this to my saved trials
BIIB023 Long-Term Extension Study in Subjects With Lupus Nephritis
A Dose-Blinded, 2-Dose Level, Parallel-Group, Multicenter, Long-Term Extension Study to Evaluate the Long-Term Safety, Efficacy, and Immunogenicity of BIIB023 in Subjects With Lupus Nephritis
Status: Enrolling
Updated:  11/12/2015
mi
from
La Plata,
BIIB023 Long-Term Extension Study in Subjects With Lupus Nephritis
A Dose-Blinded, 2-Dose Level, Parallel-Group, Multicenter, Long-Term Extension Study to Evaluate the Long-Term Safety, Efficacy, and Immunogenicity of BIIB023 in Subjects With Lupus Nephritis
Status: Enrolling
Updated: 11/12/2015
mi
from
La Plata,
Click here to add this to my saved trials
Use of an Herbal Preparation to Prevent and Dissolve Kidney Stones
Cystone for Treatment of Nephrolithiasis
Status: Enrolling
Updated:  1/4/2016
The Mayo Clinic
mi
from
Rochester, MN
Use of an Herbal Preparation to Prevent and Dissolve Kidney Stones
Cystone for Treatment of Nephrolithiasis
Status: Enrolling
Updated: 1/4/2016
The Mayo Clinic
mi
from
Rochester, MN
Click here to add this to my saved trials
Acthar in Treatment of Refractory Dermatomyositis and Polymyositis
Open Label Proof of Concept Study to Evaluate Efficacy and Safety of Adrenocorticotropic Hormone Gel in Refractory Dermatomyositis or Polymyositis
Status: Enrolling
Updated:  1/7/2016
North Shore LIJ Medical Center
mi
from
Great Neck, NY
Acthar in Treatment of Refractory Dermatomyositis and Polymyositis
Open Label Proof of Concept Study to Evaluate Efficacy and Safety of Adrenocorticotropic Hormone Gel in Refractory Dermatomyositis or Polymyositis
Status: Enrolling
Updated: 1/7/2016
North Shore LIJ Medical Center
mi
from
Great Neck, NY
Click here to add this to my saved trials
Acthar in Treatment of Refractory Dermatomyositis and Polymyositis
Open Label Proof of Concept Study to Evaluate Efficacy and Safety of Adrenocorticotropic Hormone Gel in Refractory Dermatomyositis or Polymyositis
Status: Enrolling
Updated:  1/7/2016
University of Pittsburgh
mi
from
Pittsburgh, PA
Acthar in Treatment of Refractory Dermatomyositis and Polymyositis
Open Label Proof of Concept Study to Evaluate Efficacy and Safety of Adrenocorticotropic Hormone Gel in Refractory Dermatomyositis or Polymyositis
Status: Enrolling
Updated: 1/7/2016
University of Pittsburgh
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Ultraviolet Light And Vitamin D In Subjects With Fat Malabsorption Or After Gastric Bypass Surgery
Ultraviolet Light and Vitamin D in Subjects With Fat Malabsorption or After Gastric Bypass Surgery
Status: Enrolling
Updated:  1/11/2016
Boston Med Ctr
mi
from
Boston, MA
Ultraviolet Light And Vitamin D In Subjects With Fat Malabsorption Or After Gastric Bypass Surgery
Ultraviolet Light and Vitamin D in Subjects With Fat Malabsorption or After Gastric Bypass Surgery
Status: Enrolling
Updated: 1/11/2016
Boston Med Ctr
mi
from
Boston, MA
Click here to add this to my saved trials
Determinants of Fat Malabsorption After Roux-en-Y Gastric Bypass
Surgical Treatment of Severe Obesity by Roux-en-Y Gastric Bypass: a Randomized Prospective Study on the Effect of Reciprocal Changes in Y-limb Lengths on Intestinal Absorption of Dietary Fat, Protein and Carbohydrate.
Status: Enrolling
Updated:  1/13/2016
Baylor University Medical Center
mi
from
Dallas, TX
Determinants of Fat Malabsorption After Roux-en-Y Gastric Bypass
Surgical Treatment of Severe Obesity by Roux-en-Y Gastric Bypass: a Randomized Prospective Study on the Effect of Reciprocal Changes in Y-limb Lengths on Intestinal Absorption of Dietary Fat, Protein and Carbohydrate.
Status: Enrolling
Updated: 1/13/2016
Baylor University Medical Center
mi
from
Dallas, TX
Click here to add this to my saved trials
Abatacept and Cyclophosphamide Combination Therapy for Lupus Nephritis
A Randomized, Double-Blind, Controlled, Phase II Multicenter Trial of CTLA4Ig (Abatacept) Plus Cyclophosphamide vs Cyclophosphamide Alone in the Treatment of Lupus Nephritis
Status: Enrolling
Updated:  1/15/2016
Cedars-Sinai Medical Center
mi
from
Los Angeles, CA
Abatacept and Cyclophosphamide Combination Therapy for Lupus Nephritis
A Randomized, Double-Blind, Controlled, Phase II Multicenter Trial of CTLA4Ig (Abatacept) Plus Cyclophosphamide vs Cyclophosphamide Alone in the Treatment of Lupus Nephritis
Status: Enrolling
Updated: 1/15/2016
Cedars-Sinai Medical Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Abatacept and Cyclophosphamide Combination Therapy for Lupus Nephritis
A Randomized, Double-Blind, Controlled, Phase II Multicenter Trial of CTLA4Ig (Abatacept) Plus Cyclophosphamide vs Cyclophosphamide Alone in the Treatment of Lupus Nephritis
Status: Enrolling
Updated:  1/15/2016
Emory University
mi
from
Atlanta, GA
Abatacept and Cyclophosphamide Combination Therapy for Lupus Nephritis
A Randomized, Double-Blind, Controlled, Phase II Multicenter Trial of CTLA4Ig (Abatacept) Plus Cyclophosphamide vs Cyclophosphamide Alone in the Treatment of Lupus Nephritis
Status: Enrolling
Updated: 1/15/2016
Emory University
mi
from
Atlanta, GA
Click here to add this to my saved trials
Abatacept and Cyclophosphamide Combination Therapy for Lupus Nephritis
A Randomized, Double-Blind, Controlled, Phase II Multicenter Trial of CTLA4Ig (Abatacept) Plus Cyclophosphamide vs Cyclophosphamide Alone in the Treatment of Lupus Nephritis
Status: Enrolling
Updated:  1/15/2016
University of Chicago
mi
from
Chicago, IL
Abatacept and Cyclophosphamide Combination Therapy for Lupus Nephritis
A Randomized, Double-Blind, Controlled, Phase II Multicenter Trial of CTLA4Ig (Abatacept) Plus Cyclophosphamide vs Cyclophosphamide Alone in the Treatment of Lupus Nephritis
Status: Enrolling
Updated: 1/15/2016
University of Chicago
mi
from
Chicago, IL
Click here to add this to my saved trials
Abatacept and Cyclophosphamide Combination Therapy for Lupus Nephritis
A Randomized, Double-Blind, Controlled, Phase II Multicenter Trial of CTLA4Ig (Abatacept) Plus Cyclophosphamide vs Cyclophosphamide Alone in the Treatment of Lupus Nephritis
Status: Enrolling
Updated:  1/15/2016
Rush University Medical Center
mi
from
Chicago, IL
Abatacept and Cyclophosphamide Combination Therapy for Lupus Nephritis
A Randomized, Double-Blind, Controlled, Phase II Multicenter Trial of CTLA4Ig (Abatacept) Plus Cyclophosphamide vs Cyclophosphamide Alone in the Treatment of Lupus Nephritis
Status: Enrolling
Updated: 1/15/2016
Rush University Medical Center
mi
from
Chicago, IL
Click here to add this to my saved trials
Abatacept and Cyclophosphamide Combination Therapy for Lupus Nephritis
A Randomized, Double-Blind, Controlled, Phase II Multicenter Trial of CTLA4Ig (Abatacept) Plus Cyclophosphamide vs Cyclophosphamide Alone in the Treatment of Lupus Nephritis
Status: Enrolling
Updated:  1/15/2016
Wayne State University
mi
from
Detroit, MI
Abatacept and Cyclophosphamide Combination Therapy for Lupus Nephritis
A Randomized, Double-Blind, Controlled, Phase II Multicenter Trial of CTLA4Ig (Abatacept) Plus Cyclophosphamide vs Cyclophosphamide Alone in the Treatment of Lupus Nephritis
Status: Enrolling
Updated: 1/15/2016
Wayne State University
mi
from
Detroit, MI
Click here to add this to my saved trials
Abatacept and Cyclophosphamide Combination Therapy for Lupus Nephritis
A Randomized, Double-Blind, Controlled, Phase II Multicenter Trial of CTLA4Ig (Abatacept) Plus Cyclophosphamide vs Cyclophosphamide Alone in the Treatment of Lupus Nephritis
Status: Enrolling
Updated:  1/15/2016
Seligman Center for Advanced Therapeutics (NYU)
mi
from
NY, NY
Abatacept and Cyclophosphamide Combination Therapy for Lupus Nephritis
A Randomized, Double-Blind, Controlled, Phase II Multicenter Trial of CTLA4Ig (Abatacept) Plus Cyclophosphamide vs Cyclophosphamide Alone in the Treatment of Lupus Nephritis
Status: Enrolling
Updated: 1/15/2016
Seligman Center for Advanced Therapeutics (NYU)
mi
from
NY, NY
Click here to add this to my saved trials
Abatacept and Cyclophosphamide Combination Therapy for Lupus Nephritis
A Randomized, Double-Blind, Controlled, Phase II Multicenter Trial of CTLA4Ig (Abatacept) Plus Cyclophosphamide vs Cyclophosphamide Alone in the Treatment of Lupus Nephritis
Status: Enrolling
Updated:  1/15/2016
Oklahoma Medical Research Foundation
mi
from
Oklahoma City, OK
Abatacept and Cyclophosphamide Combination Therapy for Lupus Nephritis
A Randomized, Double-Blind, Controlled, Phase II Multicenter Trial of CTLA4Ig (Abatacept) Plus Cyclophosphamide vs Cyclophosphamide Alone in the Treatment of Lupus Nephritis
Status: Enrolling
Updated: 1/15/2016
Oklahoma Medical Research Foundation
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Abatacept and Cyclophosphamide Combination Therapy for Lupus Nephritis
A Randomized, Double-Blind, Controlled, Phase II Multicenter Trial of CTLA4Ig (Abatacept) Plus Cyclophosphamide vs Cyclophosphamide Alone in the Treatment of Lupus Nephritis
Status: Enrolling
Updated:  1/15/2016
Temple University
mi
from
Philadelphia, PA
Abatacept and Cyclophosphamide Combination Therapy for Lupus Nephritis
A Randomized, Double-Blind, Controlled, Phase II Multicenter Trial of CTLA4Ig (Abatacept) Plus Cyclophosphamide vs Cyclophosphamide Alone in the Treatment of Lupus Nephritis
Status: Enrolling
Updated: 1/15/2016
Temple University
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Abatacept and Cyclophosphamide Combination Therapy for Lupus Nephritis
A Randomized, Double-Blind, Controlled, Phase II Multicenter Trial of CTLA4Ig (Abatacept) Plus Cyclophosphamide vs Cyclophosphamide Alone in the Treatment of Lupus Nephritis
Status: Enrolling
Updated:  1/15/2016
Medical University of South Carolina
mi
from
Charleston, SC
Abatacept and Cyclophosphamide Combination Therapy for Lupus Nephritis
A Randomized, Double-Blind, Controlled, Phase II Multicenter Trial of CTLA4Ig (Abatacept) Plus Cyclophosphamide vs Cyclophosphamide Alone in the Treatment of Lupus Nephritis
Status: Enrolling
Updated: 1/15/2016
Medical University of South Carolina
mi
from
Charleston, SC
Click here to add this to my saved trials
Abatacept and Cyclophosphamide Combination Therapy for Lupus Nephritis
A Randomized, Double-Blind, Controlled, Phase II Multicenter Trial of CTLA4Ig (Abatacept) Plus Cyclophosphamide vs Cyclophosphamide Alone in the Treatment of Lupus Nephritis
Status: Enrolling
Updated:  1/15/2016
University of Alabama at Birmingham
mi
from
Birmingham, AL
Abatacept and Cyclophosphamide Combination Therapy for Lupus Nephritis
A Randomized, Double-Blind, Controlled, Phase II Multicenter Trial of CTLA4Ig (Abatacept) Plus Cyclophosphamide vs Cyclophosphamide Alone in the Treatment of Lupus Nephritis
Status: Enrolling
Updated: 1/15/2016
University of Alabama at Birmingham
mi
from
Birmingham, AL
Click here to add this to my saved trials
Abatacept and Cyclophosphamide Combination Therapy for Lupus Nephritis
A Randomized, Double-Blind, Controlled, Phase II Multicenter Trial of CTLA4Ig (Abatacept) Plus Cyclophosphamide vs Cyclophosphamide Alone in the Treatment of Lupus Nephritis
Status: Enrolling
Updated:  1/15/2016
The University of California, San Diego
mi
from
La Jolla, CA
Abatacept and Cyclophosphamide Combination Therapy for Lupus Nephritis
A Randomized, Double-Blind, Controlled, Phase II Multicenter Trial of CTLA4Ig (Abatacept) Plus Cyclophosphamide vs Cyclophosphamide Alone in the Treatment of Lupus Nephritis
Status: Enrolling
Updated: 1/15/2016
The University of California, San Diego
mi
from
La Jolla, CA
Click here to add this to my saved trials
Abatacept and Cyclophosphamide Combination Therapy for Lupus Nephritis
A Randomized, Double-Blind, Controlled, Phase II Multicenter Trial of CTLA4Ig (Abatacept) Plus Cyclophosphamide vs Cyclophosphamide Alone in the Treatment of Lupus Nephritis
Status: Enrolling
Updated:  1/15/2016
University of California at San Francisco
mi
from
San Francisco, CA
Abatacept and Cyclophosphamide Combination Therapy for Lupus Nephritis
A Randomized, Double-Blind, Controlled, Phase II Multicenter Trial of CTLA4Ig (Abatacept) Plus Cyclophosphamide vs Cyclophosphamide Alone in the Treatment of Lupus Nephritis
Status: Enrolling
Updated: 1/15/2016
University of California at San Francisco
mi
from
San Francisco, CA
Click here to add this to my saved trials
Abatacept and Cyclophosphamide Combination Therapy for Lupus Nephritis
A Randomized, Double-Blind, Controlled, Phase II Multicenter Trial of CTLA4Ig (Abatacept) Plus Cyclophosphamide vs Cyclophosphamide Alone in the Treatment of Lupus Nephritis
Status: Enrolling
Updated:  1/15/2016
University of Miami
mi
from
Miami, FL
Abatacept and Cyclophosphamide Combination Therapy for Lupus Nephritis
A Randomized, Double-Blind, Controlled, Phase II Multicenter Trial of CTLA4Ig (Abatacept) Plus Cyclophosphamide vs Cyclophosphamide Alone in the Treatment of Lupus Nephritis
Status: Enrolling
Updated: 1/15/2016
University of Miami
mi
from
Miami, FL
Click here to add this to my saved trials
Abatacept and Cyclophosphamide Combination Therapy for Lupus Nephritis
A Randomized, Double-Blind, Controlled, Phase II Multicenter Trial of CTLA4Ig (Abatacept) Plus Cyclophosphamide vs Cyclophosphamide Alone in the Treatment of Lupus Nephritis
Status: Enrolling
Updated:  1/15/2016
University of Michigan
mi
from
Ann Arbor, MI
Abatacept and Cyclophosphamide Combination Therapy for Lupus Nephritis
A Randomized, Double-Blind, Controlled, Phase II Multicenter Trial of CTLA4Ig (Abatacept) Plus Cyclophosphamide vs Cyclophosphamide Alone in the Treatment of Lupus Nephritis
Status: Enrolling
Updated: 1/15/2016
University of Michigan
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Abatacept and Cyclophosphamide Combination Therapy for Lupus Nephritis
A Randomized, Double-Blind, Controlled, Phase II Multicenter Trial of CTLA4Ig (Abatacept) Plus Cyclophosphamide vs Cyclophosphamide Alone in the Treatment of Lupus Nephritis
Status: Enrolling
Updated:  1/15/2016
Feinstein Institute
mi
from
Manhasset, NY
Abatacept and Cyclophosphamide Combination Therapy for Lupus Nephritis
A Randomized, Double-Blind, Controlled, Phase II Multicenter Trial of CTLA4Ig (Abatacept) Plus Cyclophosphamide vs Cyclophosphamide Alone in the Treatment of Lupus Nephritis
Status: Enrolling
Updated: 1/15/2016
Feinstein Institute
mi
from
Manhasset, NY
Click here to add this to my saved trials
Abatacept and Cyclophosphamide Combination Therapy for Lupus Nephritis
A Randomized, Double-Blind, Controlled, Phase II Multicenter Trial of CTLA4Ig (Abatacept) Plus Cyclophosphamide vs Cyclophosphamide Alone in the Treatment of Lupus Nephritis
Status: Enrolling
Updated:  1/15/2016
Columbia University
mi
from
New York, NY
Abatacept and Cyclophosphamide Combination Therapy for Lupus Nephritis
A Randomized, Double-Blind, Controlled, Phase II Multicenter Trial of CTLA4Ig (Abatacept) Plus Cyclophosphamide vs Cyclophosphamide Alone in the Treatment of Lupus Nephritis
Status: Enrolling
Updated: 1/15/2016
Columbia University
mi
from
New York, NY
Click here to add this to my saved trials
Abatacept and Cyclophosphamide Combination Therapy for Lupus Nephritis
A Randomized, Double-Blind, Controlled, Phase II Multicenter Trial of CTLA4Ig (Abatacept) Plus Cyclophosphamide vs Cyclophosphamide Alone in the Treatment of Lupus Nephritis
Status: Enrolling
Updated:  1/15/2016
University of Rochester
mi
from
Rochester, NY
Abatacept and Cyclophosphamide Combination Therapy for Lupus Nephritis
A Randomized, Double-Blind, Controlled, Phase II Multicenter Trial of CTLA4Ig (Abatacept) Plus Cyclophosphamide vs Cyclophosphamide Alone in the Treatment of Lupus Nephritis
Status: Enrolling
Updated: 1/15/2016
University of Rochester
mi
from
Rochester, NY
Click here to add this to my saved trials
Abatacept and Cyclophosphamide Combination Therapy for Lupus Nephritis
A Randomized, Double-Blind, Controlled, Phase II Multicenter Trial of CTLA4Ig (Abatacept) Plus Cyclophosphamide vs Cyclophosphamide Alone in the Treatment of Lupus Nephritis
Status: Enrolling
Updated:  1/15/2016
UNC Chapel Hill
mi
from
CHapel Hill, NC
Abatacept and Cyclophosphamide Combination Therapy for Lupus Nephritis
A Randomized, Double-Blind, Controlled, Phase II Multicenter Trial of CTLA4Ig (Abatacept) Plus Cyclophosphamide vs Cyclophosphamide Alone in the Treatment of Lupus Nephritis
Status: Enrolling
Updated: 1/15/2016
UNC Chapel Hill
mi
from
CHapel Hill, NC
Click here to add this to my saved trials
Abatacept and Cyclophosphamide Combination Therapy for Lupus Nephritis
A Randomized, Double-Blind, Controlled, Phase II Multicenter Trial of CTLA4Ig (Abatacept) Plus Cyclophosphamide vs Cyclophosphamide Alone in the Treatment of Lupus Nephritis
Status: Enrolling
Updated:  1/15/2016
Ohio State University Medical Center
mi
from
Columbus, OH
Abatacept and Cyclophosphamide Combination Therapy for Lupus Nephritis
A Randomized, Double-Blind, Controlled, Phase II Multicenter Trial of CTLA4Ig (Abatacept) Plus Cyclophosphamide vs Cyclophosphamide Alone in the Treatment of Lupus Nephritis
Status: Enrolling
Updated: 1/15/2016
Ohio State University Medical Center
mi
from
Columbus, OH
Click here to add this to my saved trials
Abatacept and Cyclophosphamide Combination Therapy for Lupus Nephritis
A Randomized, Double-Blind, Controlled, Phase II Multicenter Trial of CTLA4Ig (Abatacept) Plus Cyclophosphamide vs Cyclophosphamide Alone in the Treatment of Lupus Nephritis
Status: Enrolling
Updated:  1/15/2016
University of Pittsburgh Lupus Center of Excellence
mi
from
Pittsburgh, PA
Abatacept and Cyclophosphamide Combination Therapy for Lupus Nephritis
A Randomized, Double-Blind, Controlled, Phase II Multicenter Trial of CTLA4Ig (Abatacept) Plus Cyclophosphamide vs Cyclophosphamide Alone in the Treatment of Lupus Nephritis
Status: Enrolling
Updated: 1/15/2016
University of Pittsburgh Lupus Center of Excellence
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Abatacept and Cyclophosphamide Combination Therapy for Lupus Nephritis
A Randomized, Double-Blind, Controlled, Phase II Multicenter Trial of CTLA4Ig (Abatacept) Plus Cyclophosphamide vs Cyclophosphamide Alone in the Treatment of Lupus Nephritis
Status: Enrolling
Updated:  1/15/2016
UT Southwestern
mi
from
Dallas, TX
Abatacept and Cyclophosphamide Combination Therapy for Lupus Nephritis
A Randomized, Double-Blind, Controlled, Phase II Multicenter Trial of CTLA4Ig (Abatacept) Plus Cyclophosphamide vs Cyclophosphamide Alone in the Treatment of Lupus Nephritis
Status: Enrolling
Updated: 1/15/2016
UT Southwestern
mi
from
Dallas, TX
Click here to add this to my saved trials
Abatacept and Cyclophosphamide Combination Therapy for Lupus Nephritis
A Randomized, Double-Blind, Controlled, Phase II Multicenter Trial of CTLA4Ig (Abatacept) Plus Cyclophosphamide vs Cyclophosphamide Alone in the Treatment of Lupus Nephritis
Status: Enrolling
Updated:  1/15/2016
Unidad de investigación en enfermedades crónico - degenerativas SC
mi
from
Guadalajara,
Abatacept and Cyclophosphamide Combination Therapy for Lupus Nephritis
A Randomized, Double-Blind, Controlled, Phase II Multicenter Trial of CTLA4Ig (Abatacept) Plus Cyclophosphamide vs Cyclophosphamide Alone in the Treatment of Lupus Nephritis
Status: Enrolling
Updated: 1/15/2016
Unidad de investigación en enfermedades crónico - degenerativas SC
mi
from
Guadalajara,
Click here to add this to my saved trials
Ceftazidime-Avibactam Compared With Doripenem Followed by Oral Therapy for Hospitalized Adults With Complicated UTIs (Urinary Tract Infections)
A Phase III, Randomized, Multicenter, Double-Blind, Double Dummy, Parallel Group, Comparative Study to Determine the Efficacy, Safety, and Tolerability of Ceftazidime Avibactam (CAZ-AVI, Formerly CAZ104) Versus Doripenem Followed by Appropriate Oral Therapy in the Treatment of Complicated Urinary Tract Infections, Including Acute Pyelonephritis, With a Gram Negative Pathogen in Hospitalized Adults
Status: Enrolling
Updated:  2/3/2016
Clinical Research Facility
mi
from
Detroit, MI
Ceftazidime-Avibactam Compared With Doripenem Followed by Oral Therapy for Hospitalized Adults With Complicated UTIs (Urinary Tract Infections)
A Phase III, Randomized, Multicenter, Double-Blind, Double Dummy, Parallel Group, Comparative Study to Determine the Efficacy, Safety, and Tolerability of Ceftazidime Avibactam (CAZ-AVI, Formerly CAZ104) Versus Doripenem Followed by Appropriate Oral Therapy in the Treatment of Complicated Urinary Tract Infections, Including Acute Pyelonephritis, With a Gram Negative Pathogen in Hospitalized Adults
Status: Enrolling
Updated: 2/3/2016
Clinical Research Facility
mi
from
Detroit, MI
Click here to add this to my saved trials